Advanced Search

 

Study ID Status Title Patient Level Data
H34/107-STW881 Completed The pharmacokinetics of lamotrigine in chronic renal failure: Influence of haemodialysis
H34/V/AFC/84/01 Completed Pharmacokinetics of Lamotrigine After Oral and Intravenous Infusion Administration in Normal Volunteers
H34-035-C86 Completed A Multicentre Randomised Double-Blind Placebo Controlled Crossover Trial of Lamotrigine (LTG) as Add-On Therapy in Treatment-Resistant Epilepsy: Australia
H34-049-C87/H34-089-C88 Completed A Multicentre, Double Blind Comparison of the Efficacy and Safety of Lamotrigine and Carbamazepine Monotherapy in Patients with Newly Diagnosed Epilepsy
H34-074-C87 Completed A multicenter, double-blind comparison of the efficacy and safety of lamotrigine and phenytoin monotherapy in patients with newly diagnosed epilepsy.
H3A106104 Terminated An Open Label, Dose Escalation Study With A Double Blind Randomised Placebo Controlled Withdrawal To Examine The Effects Of The Histamine H3 Antagonist GSK189254 In Patients With Narcolepsy.
H3A106308 Completed A double-blind, double-dummy, placebo-controlled, incomplete block, two period crossover study of the histamine H3 antagonist GSK189254 and duloxetine in the electrical hyperalgesia model of central sensitisation in healthy volunteers
H3B109689 Completed A single blind, placebo-controlled, randomised study in mild to moderate Alzheimer’s disease patients to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK239512, a selective histamine H3 receptor antagonist Study Listed on ClinicalStudyDataRequest.com
H73-020-V Completed The Effects of Probenecid and Cimetidine on the Pharmacokinetics of Valaciclovir and its Metabolite Acyclovir in Healthy Male Volunteers
HAZ30001 Completed A prospective, randomised, open-label, blinded-endpoint, parallel group study comparing telmisartan plus hydrochlorothiazide with losartan plus hydrochlorothiazide in subjects with essential hypertension.
HAZ30002 Completed A prospective, randomised, open-label, parallel group study to investigate the effects of 12 months treatment with telmisartan plus hydrochlorothiazide or ramipril plus hydrochlorothiazide on left ventricular mass index in subjects with left ventricular hypertrophy and essential hypertension
HGC10007 Completed A randomised, placebo controlled, parallel group pilot study in patients with allergic rhinitis due to house dust mite to determine i) the effectiveness of 7 days treatment with fluticasone propionate 200 m/day, upon nasal clinical response and nasal biopsy after intranasal allergen challenge…
HGC10008 Completed A randomised, double-blind, double-dummy, placebo-controlled, three-way crossover study in patients with allergic rhinitis due to house dust mite to compare the effect versus placebo of 7 days treatment with a new chemical entity (NCE) administered…
HGS1021-C1063 Completed A randomized, single-blind, placebo-controlled study to evaluate the safety and tolerability of raxibacumab (human monoclonal antibody to B. anthracis protective antigen) in healthy subjects Study Listed on ClinicalStudyDataRequest.com
HGS1021-C1069 Completed An Open-Label Study to Evaluate the Immunogenicity and Safety of Raxibacumab (Human Monoclonal Antibody to B. anthracis Protective Antigen) Administered in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
HH3104994 Completed A randomised, double blind, placebo controlled, two way crossover, three phase study to investigate the trial models; Vienna Challenge Chamber, in and out of season and Park study in season and the clinical efficacy of repeat doses of fluticasone propionate in subjects with seasonal allergic rhinitis (SAR).
HH3110161 Completed A double-blind, placebo-controlled, randomized cross-over single dose escalation study and a double-blind, placebo-controlled, randomised parallel group 7-days once daily repeat dose study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of oral H1/H3 dual antagonist compound in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
HHI110157 Completed A double-blind, placebo-controlled, randomized single dose escalation study and a double-blind, placebo-controlled, randomised parallel group 14-days once daily repeat dose study to investigate safety, tolerability and pharmacokinetics of an intranasal H1/H3 dual antagonist compound in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
HM2006/00198/00 Completed A randomised, double-blind, parallel-group, placebo controlled study to investigate the anxiolytic effects of repeat dosing of 20mg and 40mg paroxetine.
HPR20001 Terminated Phase IIB, Randomized, Multicenter, Parallel Group, Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effect of Four Blinded Dosing Regimens of GW640385X/ritonavir Compared to Open-label Current PI therapy in HIV-1 infected, Protease Inhibitor Experienced Adults for 2 weeks with Long-term Assessment (>48 weeks) of Safety, Pharmacokinetic and Antiviral Activity of Selected 385/RTV Dosing Regimen(s) vs. a Ritonavir-boosted, Protease Inhibitor Containing Regimen
HPV-Meta-analysis-201110 Completed Integrated Safety Summary of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (Cervarix®)
HS2100275 Completed An International, Randomized, Double-Blind, Placebo-Controlled, Multicenter, 6-Month Study of the Efficacy and Safety of Valtrex 1g QD vs. Placebo for the Suppression of HSV-2 Genital Herpes in Newly Diagnosed Immunocompetent Patients Study Listed on ClinicalStudyDataRequest.com
HS2101951 Completed Clinical Evaluation of Valaciclovir Hydrochloride: 256U87 in Patients with Chickenpox - Open Uncontrolled Study.
HS210909 Completed Report of a Study to Evaluate the Bioequivalence of Single Doses of an Investigational Formulation of Valaciclovir Compared to the Standard Valaciclovir Tablet in Healthy Volunteers
HS210911 Completed A Randomised, Open-Label, Cross-Over, Single Dose Study to Evaluate the Pharmacokinetic Interaction Between Aciclovir 800mg and Mycophenolate Mofetil 1000mg and Between Valaciclovir 2000mg and Mycophenolate Mofetil 1000mg in Healthy Volunteers

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.